OTC : CLZNY
$0 (0.0%)
| Source | Headline |
|---|---|
|
Clariant AG (CLZNY) Q1 2026 Earnings Call Transcript
Clariant AG (CLZNY) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-08 15:01:19 |
|
Clariant delivers resilient performance in challenging environment
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR FIRST QUARTER | 2026 Q1 2026 sales decreased by 2 % in local currencies 1 to CHF 918 million with the Middle East conflict impacting Catalyst volumes and portfolio pruning affecting Care Chemicals; 0.5 % decline excluding portfolio pruning Q1 2026 EBITDA margin before exceptional items of 17.5 % decreased by 130 basis points compared to a strong Q1 2025 mainly due to the Middle East conflict and a one-off impacting Catalysts Q1 2026 free cash flow conversion improved by 12 percentage points to 54 % (LTM basis), achieved through effective net working capital management and continued disciplined Capex On track to achieve the remaining CHF 30 million of the total CHF 80 million performance improvement program savings (Investor Day 2024) already in 2026, with CHF 9 million achieved in the first quarter Guidance 2026 remains unchanged while Middle East conflict particularly impacting demand in our Catalysts business, causing increasing input costs, and overall elevated uncertainty and volatility “In the first quarter of 2026, Clariant delivered flat underlying sales, excluding the effects of our proactive portfolio pruning measures. globenewswire.com - 2026-05-08 01:00:00 |